Exchange: OTC·Updated 12:09 PM EDT

ZVSA News

News
all
press releases
Retail Traders Flock To ZyVersa As IC 100 Obesity Plan Looks To Fill GLP-1 Gaps
ZyVersa's IC 100 strategy focuses on targeting inflammasome-driven inflammation to enhance weight loss and improve metabolic function in obesity patients.
Stocktwits

Advertisement|Remove ads.